Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | thyroid hormone receptor, beta | Starlite/ChEMBL | No references |
Escherichia coli | penicillin-binding protein | Starlite/ChEMBL | No references |
Homo sapiens | muscleblind-like splicing regulator 1 | Starlite/ChEMBL | No references |
Species | Potential target | Known druggable target | Length | Alignment span | Identity |
---|---|---|---|---|---|
Brugia malayi | photoreceptor-specific nuclear receptor | thyroid hormone receptor, beta | 461 aa | 414 aa | 24.6 % |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Mycobacterium ulcerans | fusion of enoyl-CoA hydratase, EchA21 and lipase, LipE | 0.0043 | 0.1178 | 0.5 |
Echinococcus multilocularis | thyroid hormone receptor alpha | 0.0164 | 0.5724 | 0.9039 |
Trichomonas vaginalis | D-aminoacylase, putative | 0.0043 | 0.1178 | 0.5 |
Loa Loa (eye worm) | beta-lactamase | 0.0043 | 0.1178 | 0.1859 |
Mycobacterium ulcerans | lipase LipD | 0.0043 | 0.1178 | 0.5 |
Trichomonas vaginalis | penicillin-binding protein, putative | 0.0043 | 0.1178 | 0.5 |
Brugia malayi | beta-lactamase family protein | 0.0043 | 0.1178 | 0.1859 |
Trypanosoma cruzi | hypothetical protein, conserved | 0.0043 | 0.1178 | 0.5 |
Trichomonas vaginalis | esterase, putative | 0.0043 | 0.1178 | 0.5 |
Leishmania major | hypothetical protein, conserved | 0.0043 | 0.1178 | 0.5 |
Echinococcus multilocularis | beta LACTamase domain containing family member | 0.0043 | 0.1178 | 0.1859 |
Loa Loa (eye worm) | hypothetical protein | 0.018 | 0.6333 | 1 |
Echinococcus granulosus | muscleblind protein | 0.018 | 0.6333 | 1 |
Mycobacterium leprae | conserved hypothetical protein | 0.0043 | 0.1178 | 0.5 |
Echinococcus granulosus | Mitotic checkpoint protein PRCC C terminal | 0.0152 | 0.5265 | 0.8314 |
Loa Loa (eye worm) | hypothetical protein | 0.0043 | 0.1178 | 0.1859 |
Loa Loa (eye worm) | hypothetical protein | 0.0043 | 0.1178 | 0.1859 |
Schistosoma mansoni | family S12 unassigned peptidase (S12 family) | 0.0043 | 0.1178 | 0.2057 |
Onchocerca volvulus | 0.0043 | 0.1178 | 1 | |
Brugia malayi | Hypothetical 52.5 kDa protein ZK945.1 in chromosome II, putative | 0.0043 | 0.1178 | 0.1859 |
Trichomonas vaginalis | D-aminoacylase, putative | 0.0043 | 0.1178 | 0.5 |
Loa Loa (eye worm) | beta-LACTamase domain containing family member | 0.0043 | 0.1178 | 0.1859 |
Loa Loa (eye worm) | hypothetical protein | 0.0043 | 0.1178 | 0.1859 |
Onchocerca volvulus | 0.0043 | 0.1178 | 1 | |
Brugia malayi | Muscleblind-like protein | 0.018 | 0.6333 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0043 | 0.1178 | 0.1859 |
Trypanosoma cruzi | hypothetical protein, conserved | 0.0043 | 0.1178 | 0.5 |
Schistosoma mansoni | thyroid hormone receptor | 0.0164 | 0.5724 | 1 |
Toxoplasma gondii | ABC1 family protein | 0.0043 | 0.1178 | 0.5 |
Mycobacterium ulcerans | beta-lactamase | 0.0043 | 0.1178 | 0.5 |
Schistosoma mansoni | family S12 unassigned peptidase (S12 family) | 0.0043 | 0.1178 | 0.2057 |
Loa Loa (eye worm) | hypothetical protein | 0.018 | 0.6333 | 1 |
Mycobacterium leprae | Probable lipase LipE | 0.0043 | 0.1178 | 0.5 |
Brugia malayi | beta-lactamase family protein | 0.0043 | 0.1178 | 0.1859 |
Echinococcus multilocularis | muscleblind protein 1 | 0.018 | 0.6333 | 1 |
Mycobacterium ulcerans | esterase/lipase LipP | 0.0043 | 0.1178 | 0.5 |
Mycobacterium ulcerans | hypothetical protein | 0.0043 | 0.1178 | 0.5 |
Onchocerca volvulus | 0.0043 | 0.1178 | 1 | |
Loa Loa (eye worm) | hypothetical protein | 0.0043 | 0.1178 | 0.1859 |
Echinococcus multilocularis | Mitotic checkpoint protein PRCC, C terminal | 0.0152 | 0.5265 | 0.8314 |
Schistosoma mansoni | hypothetical protein | 0.0152 | 0.5265 | 0.9197 |
Echinococcus multilocularis | muscleblind protein | 0.018 | 0.6333 | 1 |
Trichomonas vaginalis | D-aminoacylase, putative | 0.0043 | 0.1178 | 0.5 |
Trichomonas vaginalis | penicillin-binding protein, putative | 0.0043 | 0.1178 | 0.5 |
Brugia malayi | beta-lactamase | 0.0043 | 0.1178 | 0.1859 |
Echinococcus granulosus | beta LACTamase domain containing family member | 0.0043 | 0.1178 | 0.1859 |
Loa Loa (eye worm) | hypothetical protein | 0.0043 | 0.1178 | 0.1859 |
Trypanosoma brucei | hypothetical protein, conserved | 0.0043 | 0.1178 | 0.5 |
Plasmodium vivax | hypothetical protein, conserved | 0.0043 | 0.1178 | 0.5 |
Schistosoma mansoni | thyroid hormone receptor | 0.0164 | 0.5724 | 1 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Potency (functional) | = 0.0001 um | PUBCHEM_BIOASSAY: Total Fluorescence Counterscreen for Inhibitors of the Interaction of Thyroid Hormone Receptor and Steroid Receptor Coregulator 2. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | = 1.7783 um | PUBCHEM_BIOASSAY: qHTS Inhibitors of AmpC Beta-Lactamase (assay with detergent). (Class of assay: confirmatory) [Related pubchem assays: 1002 (Confirmation Concentration-Response Assay for Inhibitors of AmpC Beta-Lactamase (assay with detergent)), 585 (Promiscuous and Specific Inhibitors of AmpC Beta-Lactamase (assay without detergent) - a screen old NIH MLSMR collection), 584 (Promiscuous and Specific Inhibitors of AmpC Beta-Lactamase (assay with detergent) - a screen of the old NIH MLSMR collection), 1003 (Confirmation Cuvette-Based Assay for Inhibitors of AmpC Beta-Lactamase (assay with detergent))] | ChEMBL. | No reference |
Potency (binding) | 7.0795 uM | PubChem BioAssay. qHTS Assay for Inhibitors of MBNL1-poly(CUG) RNA binding. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 89.1251 uM | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Histone Lysine Methyltransferase G9a. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504404] | ChEMBL. | No reference |
Potency (functional) | 89.1251 uM | PUBCHEM_BIOASSAY: qHTS for Inhibitors of Polymerase Iota. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588623] | ChEMBL. | No reference |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.